Tsuchimoto Kim R
Insider CIK 1333516 · RPTP Chief Financial Officer · MNPR Chief Financial Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-08-26 | 2026-08-28 | 2,055 | — | $0 | 6,165 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-08-26 | 2026-08-28 | 2,035 | — | $0 | 8,140 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 485 | $108.83 | $52.8K | 11,001 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 590 | $113.84 | $67.2K | 7,396 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 615 | $109.56 | $67.4K | 10,386 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 700 | $110.65 | $77.5K | 9,686 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 1,098 | $111.84 | $122.8K | 8,588 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 602 | $112.93 | $68.0K | 7,986 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 1,098 | $111.84 | $122.8K | 1,192 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-08-26 | 2026-08-28 | 2,055 | $30.00 | $61.6K | 2,055 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-08-26 | 2026-08-28 | 2,035 | $14.00 | $28.5K | 4,090 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 485 | $108.83 | $52.8K | 3,605 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 615 | $109.56 | $67.4K | 2,990 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 590 | $113.84 | $67.2K | 0 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 602 | $112.93 | $68.0K | 590 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 700 | $110.65 | $77.5K | 2,290 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 590 | $113.84 | $67.2K | 7,396 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 602 | $112.93 | $68.0K | 7,986 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 1,098 | $111.84 | $122.8K | 8,588 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 700 | $110.65 | $77.5K | 9,686 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 615 | $109.56 | $67.4K | 10,386 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-27 | 485 | $108.83 | $52.8K | 11,001 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-08-26 | 2026-08-28 | 2,035 | — | $0 | 8,140 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2026-08-26 | 2026-08-28 | 2,055 | — | $0 | 6,165 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 590 | $113.84 | $67.2K | 0 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 602 | $112.93 | $68.0K | 590 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 1,098 | $111.84 | $122.8K | 1,192 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 700 | $110.65 | $77.5K | 2,290 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 615 | $109.56 | $67.4K | 2,990 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2026-08-26 | 2026-08-28 | 485 | $108.83 | $52.8K | 3,605 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-08-26 | 2026-08-28 | 2,035 | $14.00 | $28.5K | 4,090 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2026-08-26 | 2026-08-28 | 2,055 | $30.00 | $61.6K | 2,055 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-12-02 | 2025-12-08 | 2,924 | — | $0 | 2,924 | SEC↗ |
| MNPR Monopar Therapeutics | X Exercise deriv | 2025-07-14 | 2025-07-16 | 4,704 | — | $0 | 0 | SEC↗ |
| MNPR Monopar Therapeutics | X Exercise deriv | 2025-07-14 | 2025-07-16 | 4,200 | — | $0 | 0 | SEC↗ |
| MNPR Monopar Therapeutics | S Sale | 2025-07-14 | 2025-07-16 | 8,904 | $40.00 | $356.2K | 11,486 | SEC↗ |
| MNPR Monopar Therapeutics | X Exercise | 2025-07-14 | 2025-07-16 | 8,904 | $0.01 | $89 | 20,390 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2025-03-04 | 2025-03-07 | 11,365 | — | $0 | 11,365 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-06-30 | 2024-07-02 | 9,957 | — | $0 | 74,412 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-06-30 | 2024-07-02 | 9,957 | — | $0 | 60,427 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-06-30 | 2024-07-02 | 2,998 | $0.73 | $2.2K | 57,429 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-03-31 | 2024-04-02 | 9,956 | — | $0 | 84,369 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-03-31 | 2024-04-02 | 4,082 | $0.68 | $2.8K | 50,470 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-03-31 | 2024-04-02 | 9,956 | — | $0 | 54,552 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2024-01-01 | 2024-01-03 | 1,231 | — | $0 | 94,325 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2024-01-01 | 2024-01-03 | 1,231 | — | $0 | 45,101 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2024-01-01 | 2024-01-03 | 505 | $0.34 | $172 | 44,596 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-12-31 | 2024-01-03 | 9,957 | — | $0 | 95,556 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-12-31 | 2024-01-03 | 4,073 | $0.34 | $1.4K | 43,870 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-12-31 | 2024-01-03 | 9,957 | — | $0 | 47,943 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-09-30 | 2023-10-03 | 9,956 | — | $0 | 105,513 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-09-30 | 2023-10-03 | 9,956 | — | $0 | 41,430 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-09-30 | 2023-10-03 | 3,444 | $0.62 | $2.1K | 37,986 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-06-30 | 2023-07-03 | 14,846 | — | $0 | 115,469 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-06-30 | 2023-07-03 | 5,104 | $0.86 | $4.4K | 31,474 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-06-30 | 2023-07-03 | 14,846 | — | $0 | 36,578 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-03-31 | 2023-04-04 | 5,067 | — | $0 | 130,315 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-03-31 | 2023-04-04 | 5,067 | — | $0 | 23,574 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-03-31 | 2023-04-04 | 1,842 | $1.39 | $2.6K | 21,732 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2023-02-01 | 2023-02-03 | 102,688 | — | $0 | 102,688 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2023-02-01 | 2023-02-03 | 78,234 | — | $0 | 135,382 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2023-01-01 | 2023-01-03 | 1,230 | — | $0 | 1,231 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2023-01-01 | 2023-01-03 | 1,230 | — | $0 | 19,009 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2023-01-01 | 2023-01-03 | 502 | $2.37 | $1.2K | 18,507 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-12-31 | 2023-01-03 | 5,067 | — | $0 | 55,917 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-12-31 | 2023-01-03 | 2,067 | $2.37 | $4.9K | 17,779 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-12-31 | 2023-01-03 | 5,067 | — | $0 | 19,846 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-09-30 | 2022-10-03 | 5,066 | — | $0 | 63,445 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-09-30 | 2022-10-03 | 1,753 | $1.52 | $2.7K | 14,779 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-09-30 | 2022-10-03 | 5,066 | — | $0 | 16,532 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-06-30 | 2022-07-01 | 8,913 | — | $0 | 68,511 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-06-30 | 2022-07-01 | 3,083 | $2.30 | $7.1K | 11,466 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-06-30 | 2022-07-01 | 8,913 | — | $0 | 14,549 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-03-31 | 2022-04-01 | 1,221 | — | $0 | 77,424 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-03-31 | 2022-04-01 | 500 | $2.55 | $1.3K | 5,636 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-03-31 | 2022-04-01 | 1,221 | — | $0 | 6,136 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2022-02-02 | 2022-02-04 | 81,395 | — | $0 | 81,395 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2022-02-02 | 2022-02-04 | 61,532 | — | $0 | 78,645 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2022-01-01 | 2022-01-04 | 1,231 | — | $0 | 2,461 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2022-01-01 | 2022-01-04 | 505 | $3.21 | $1.6K | 4,915 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2022-01-01 | 2022-01-04 | 1,231 | — | $0 | 5,420 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-12-31 | 2022-01-04 | 1,221 | — | $0 | 14,652 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-12-31 | 2022-01-04 | 1,221 | — | $0 | 4,690 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-12-31 | 2022-01-04 | 501 | $3.21 | $1.6K | 4,189 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-09-30 | 2021-10-01 | 1,221 | — | $0 | 15,873 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-09-30 | 2021-10-01 | 423 | $4.87 | $2.1K | 3,469 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-09-30 | 2021-10-01 | 1,221 | — | $0 | 3,892 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-06-30 | 2021-07-02 | 2,442 | — | $0 | 17,094 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-06-30 | 2021-07-02 | 2,442 | — | $0 | 3,494 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-06-30 | 2021-07-02 | 823 | $5.89 | $4.8K | 2,671 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2021-01-26 | 2021-01-28 | 27,427 | — | $0 | 27,427 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2021-01-26 | 2021-01-28 | 19,536 | — | $0 | 23,228 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise deriv | 2021-01-01 | 2021-01-05 | 1,231 | — | $0 | 3,692 | SEC↗ |
| MNPR Monopar Therapeutics | M Exercise | 2021-01-01 | 2021-01-05 | 1,231 | — | $0 | 1,556 | SEC↗ |
| MNPR Monopar Therapeutics | F Tax w/h | 2021-01-01 | 2021-01-05 | 504 | $6.12 | $3.1K | 1,052 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2020-01-31 | 2020-02-20 | 4,923 | — | $0 | 4,923 | SEC↗ |
| MNPR Monopar Therapeutics | A Award deriv | 2020-01-31 | 2020-02-20 | 20,455 | — | $0 | 20,455 | SEC↗ |
| MNPR Monopar Therapeutics | P Buy | 2019-12-18 | 2019-12-20 | 325 | $8.00 | $2.6K | 325 | SEC↗ |
| NONE Monopar Therapeutics | A Award deriv | 2018-08-28 | 2018-09-27 | 41,100 | — | $0 | 85,620 | SEC↗ |
| NONE Monopar Therapeutics | A Award deriv | 2018-08-28 | 2018-09-27 | 41,100 | — | $0 | 41,100 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | A Award deriv | 2012-09-25 | 2012-09-27 | 39,000 | — | $0 | 441,925 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2012-08-29 | 2012-08-31 | 189 | — | $0 | 402,925 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2012-08-29 | 2012-08-31 | 3,321 | — | $0 | 403,114 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2012-08-29 | 2012-08-31 | 3,510 | $5.00 | $17.6K | 582 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2012-08-29 | 2012-08-31 | 3,321 | $2.57 | $8.5K | 3,903 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2012-08-29 | 2012-08-31 | 189 | $2.57 | $486 | 4,092 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2012-08-27 | 2012-08-29 | 49 | — | $0 | 406,435 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2012-08-27 | 2012-08-29 | 49 | $5.00 | $245 | 582 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2012-08-27 | 2012-08-29 | 49 | $2.57 | $126 | 631 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2012-06-15 | 2012-06-18 | 3,559 | — | $0 | 406,484 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2012-06-15 | 2012-06-18 | 3,559 | $5.77 | $20.5K | 582 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2012-06-15 | 2012-06-18 | 3,559 | $2.57 | $9.1K | 4,141 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2012-04-16 | 2012-04-17 | 3,559 | — | $0 | 410,043 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2012-04-16 | 2012-04-17 | 3,559 | $2.57 | $9.1K | 4,141 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2012-04-16 | 2012-04-17 | 3,559 | $6.05 | $21.5K | 582 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise deriv | 2012-02-15 | 2012-02-16 | 3,559 | — | $0 | 413,602 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | M Exercise | 2012-02-15 | 2012-02-16 | 3,559 | $2.57 | $9.1K | 4,141 | SEC↗ |
| RPTP Raptor Pharmaceutical Corp | S Sale | 2012-02-15 | 2012-02-16 | 3,559 | $7.74 | $27.5K | 582 | SEC↗ |